27.88 USD
↘ 0.45 (1.59%)AT CLOSE (11:59 AM EDT)
Roivant Sciences Ltd. Common Shares
ROIVNASDAQ • USD
27.90
↗ 0.01 (0.04%)
POST MARKET (AS OF 04:56 PM EDT)
Post Market
AS OF 04:56 PM EDT
27.90
↗ 0.01 (0.04%)
Market: OPEN
Open?$28.06
High?$28.45
Low?$27.70
Prev. Close?$28.33
Volume?5.8M
Avg. Volume?5.8M
VWAP?$28.03
Rel. Volume?1.00x
Bid / Ask
Bid?$26.69 × 100
Ask?$29.26 × 100
Spread?$2.57
Midpoint?$27.98
Valuation & Ratios
Market Cap?20.3B
Shares Out?715.7M
Float?371.0M
Float %?51.8%
P/E Ratio?N/A
P/B Ratio?4.75
EPS?-$1.13
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?30.66Strong
Quick Ratio?30.66Strong
Cash Ratio?9.73Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?4.75FAIR▾
P/S?1,523.35HIGH▾
P/FCF?N/A▾
EV/EBITDA?-15.5CHEAP▾
EV/Sales?1,412.29HIGH▾
Returns & Efficiency
ROE?-19.0%WEAK▾
ROA?-15.5%WEAK▾
Cash Flow & Enterprise
FCF?$-766855000
Enterprise Value?$18.8B
Related Companies
Loading...
News
Profile
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Employees
750
Market Cap
20.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-01
Address
7TH FLOOR, 50 BROADWAY
LONDON, SW1H 0DB
Phone: 441-295-5950
LONDON, SW1H 0DB
Phone: 441-295-5950